Lv7
4690 积分 2023-04-13 加入
Challenging the myths of subcutaneous delivery: An industry expert perspective
3天前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
4天前
已完结
Brain-shuttle biologics chart new paths across the blood-brain barrier
6天前
已完结
T cell engagers in autoimmune diseases
18天前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
1个月前
已完结
Integrating China’s Oncology Innovations into the Global Landscape: A Strategic Blueprint for Precision, Partnership, and Purpose
1个月前
已完结
Trends in target novelty in oncology R&D
1个月前
已完结
Challenges for Chinese innovative cancer drugs in going global: insights from multiregional clinical trials
1个月前
已完结
Trends in the landscape of clinical trials of innovative drugs in China since 2015
1个月前
已完结
Comparative analysis of manufacturability and binding of various bispecific antibody architectures
2个月前
已完结
皖公网安备34019202002308
